Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
146
146 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- BRM421Phase 21 trial
BRIM Biotechnology Inc. · Dry Eye Disease (DED), Keratoconjunctivitis Sicca
- BTV100Phase 21 trial
BioTheraVision, Inc. · Dry Eye
- CPK850Phase 21 trial
Novartis · Retinitis Pigmentosa
- CU06-1004Phase 21 trial
Curacle Co., Ltd. · DME, Diabetic Macular Edema, Diabetic Macular Edema (DME)
- EG-301Phase 21 trial
Evergreen Therapeutics, Inc. · Non-Exudative (Dry) Age-related Macular Degeneration (dAMD)
- ENN0403Phase 21 trial
EnnovaBio · Diabetic Macular Edema (DME)
- EXG202Phase 21 trial
Guangzhou Jiayin Biotech Ltd · Wet Age-related Macular Degeneration
- famzeretcelhuman retinal progenitor cells, jCellPhase 21 trial
jCyte, Inc · Retinitis Pigmentosa
- FWY003Phase 21 trial
Novartis · Geographic Atrophy Secondary to Age-related Macular Degeneration
- FXS5626Phase 21 trial
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. · Active Non-anterior, Non-infectious Uveitis
- GVB-2001Phase 21 trial
IVIEW Therapeutics Inc. · Primary Open-Angle Glaucoma (POAG)
- HX9428Phase 21 trial
Fujian Haixi Pharmaceuticals Co., Ltd. · Wet Age-related Macular Degeneration (AMD)
- intraocular implant releasing timololTimoD implantPhase 21 trial
EyeD Pharma · Glaucoma, Ocular Hypertension
- INV-102Phase 21 trial
Invirsa, Inc. · Non-center Involved Diabetic Macular Edema, Non-center Involved Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy, Diabetic Retinopathy
- IOV-3001Phase 21 trial
Iovance Biotherapeutics, Inc. · Unresectable Melanoma, Metastatic Melanoma, Ocular Melanoma
- KH631Phase 21 trial
Chengdu Origen Biotechnology Co., Ltd. · Age-Related Macular Degeneration
- KH658Phase 21 trial
Chengdu Origen Biotechnology Co., Ltd. · Age-related Macular Degeneration
- KIO-104Phase 21 trial
Kiora Pharmaceuticals, Inc. · Macular Edema
- KIO-301Phase 21 trial
Kiora Pharmaceuticals, Inc. · Retinitis Pigmentosa
- KUS121Phase 21 trial
Kyoto Drug Discovery and Development Co., Ltd. · Central Retinal Artery Occlusion
- NGGT001Phase 21 trial
NGGT (Suzhou) Biotechnology Co., Ltd. · Bietti Crystalline Corneoretinal Dystrophy
- OCU400Phase 21 trial
Ocugen · Retinitis Pigmentosa, Leber Congenital Amaurosis
- OHB-607Mecasermin RinfabatePhase 21 trial
OHB Neonatology Ltd. · Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Intraventricular Hemorrhage
- OpCT-001Phase 21 trial
BlueRock Therapeutics · Primary Photoreceptor Disease, Retinitis Pigmentosa (RP), Usher Syndrome
- OXU-001DEXAspheresPhase 21 trial
Oxular Limited · Diabetic Macular Edema
- PG043Phase 21 trial
Alcon Research · Open Angle Glaucoma, Ocular Hypertension
- PST-611Phase 21 trial
Eyevensys · Geographic Atrophy, Age - Related Macular Degeneration (AMD)
- QR-1123Phase 21 trial
ProQR Therapeutics · Autosomal Dominant Retinitis Pigmentosa, Eye Diseases, Eye Diseases, Hereditary
- REGN22530Phase 21 trial
Regeneron · Primary Open Angle Glaucoma (POAG), Ocular Hypertension (OHT)
- RO7446603Phase 21 trial
Roche (Genentech) · Diabetic Macular Edema
- RO7965032Phase 21 trial
Roche (Genentech) · Geographic Atrophy Secondary to Age-Related Macular Degeneration
- RRG001Phase 21 trial
Shanghai Refreshgene Technology Co., Ltd. · Neovascular Age-related Macular Degeneration
- SAR402663Phase 21 trial
Sanofi · Neovascular Age-related Macular Degeneration
- SNP318Phase 21 trial
SciNeuro · Diabetic Macular Edema, DME
- SOM-401Phase 21 trial
Inflammasome Therapeutics · Geographic Atrophy, Age-Related Macular Degeneration
- SPVN06Phase 21 trial
SparingVision · Retinitis Pigmentosa
- SPVN20Phase 21 trial
SparingVision · Retinitis Pigmentosa (RP), Rod Cone Dystrophy
- SUM-191Phase 21 trial
Senju USA, Inc. · Bacterial Conjunctivitis
- SYL1801Phase 21 trial
Sylentis, S.A. · Wet Macular Degeneration, Neovascular Age-related Macular Degeneration, Macular Degeneration
- T1695Phase 21 trial
Laboratoires Thea · Moderate to Severe Vernal Keratoconjunctivitis
- TJO-087Phase 21 trial
Taejoon Pharmaceutical Co., Ltd. · Dry Eye Syndrome (DES)
- VG801Phase 21 trial
VeonGen Therapeutics GmbH · Retinal Dystrophy Due to Biallelic ABCA4 Mutations, Stargardt Disease 1
- VOY-101Phase 21 trial
Perceive Biotherapeutics, Inc. · Age-Related Macular Degeneration, Geographic Atrophy, Non-neovascular AMD
- VP-001Phase 21 trial
PYC Therapeutics · Retinitis Pigmentosa 11, Retinal Degeneration, Retinal Disease
- VSJ-110Phase 21 trial
Vanda Pharmaceuticals · Dry Eye
- VX-01Phase 21 trial
Vantage Biosciences Ltd · Diabetic Retinopathy, NPDR - Non Proliferative Diabetic Retinopathy
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.